Clinical Trials on GD2-positive Solid Tumors
Total 5394 results
-
SCRI Development Innovations, LLCNovartisTerminated
-
Washington University School of MedicineCompleted
-
Galapagos NVCompletedSolid TumorsNetherlands
-
National University Hospital, SingaporeUnknownAdvanced Solid TumorsSingapore
-
Centre Hospitalier Universitaire DijonCompleted
-
Oncoethix GmbHUnknown
-
National University Hospital, SingaporeCompleted
-
M.D. Anderson Cancer CenterTaiho Pharmaceutical Co., Ltd.Completed
-
M.D. Anderson Cancer CenterAlaunos TherapeuticsCompleted
-
Alaunos TherapeuticsCompleted
-
Alaunos TherapeuticsCompleted
-
AstraZenecaCompletedSolid TumorsUnited States, France, United Kingdom
-
Genta IncorporatedCompleted
-
Hanmi Pharmaceutical Company LimitedCompleted
-
Mateon TherapeuticsCancer Research UKCompleted
-
Hadassah Medical OrganizationNovartisWithdrawnMetastatic Solid Tumors.Israel
-
Hadassah Medical OrganizationWithdrawnMetastatic Solid TumorsIsrael
-
SCRI Development Innovations, LLCNovartisCompleted
-
Eli Lilly and CompanyCompletedSolid TumorsNetherlands
-
Clavis PharmaCompletedSolid TumorsNetherlands, Belgium
-
Cellectar, IncCompletedSolid TumorsUnited States
-
Metastatix, Inc.SuspendedSolid TumorsUnited States
-
AstraZenecaTerminatedCancer | Advanced Solid Tumors | Advanced Solid MalignanciesUnited States
-
Bio-Thera SolutionsPeking University Cancer Hospital & InstituteRecruitingMelanoma | Advanced Solid TumorChina
-
Imugene LimitedRecruitingSolid Tumor | Metastatic Cancer | Advanced Solid Tumor | Solid Tumor, Adult | Solid CarcinomaUnited States, Australia
-
Bio-Thera SolutionsNot yet recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruiting
-
Bristol-Myers SquibbRecruitingCancer | Solid TumorsFrance
-
New Cancer Cure-Bio Co.,Ltd.RecruitingAdvanced Solid TumorsKorea, Republic of
-
TakedaRecruiting
-
Bio-Thera SolutionsNot yet recruiting
-
Boehringer IngelheimRecruitingSolid TumorsSpain, Japan, United Kingdom, United States
-
Mabwell (Shanghai) Bioscience Co., Ltd.Recruiting
-
AkesoNot yet recruiting
-
ORIC PharmaceuticalsRecruitingPh 1/2 Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 AlterationSolid TumorsKorea, Republic of, United States, Australia, Canada
-
Harbour BioMed (Guangzhou) Co. Ltd.Not yet recruiting
-
Boehringer IngelheimRecruitingSolid TumorsUnited States, Spain, Germany, Austria, France, Belgium
-
Onconova Therapeutics, Inc.Recruiting
-
Genentech, Inc.RecruitingSolid TumorsKorea, Republic of, Netherlands, Spain, United States, Brazil, Canada, Italy, Australia, Belgium
-
National Cancer Institute (NCI)RecruitingNeoplasms | Solid TumorsUnited States
-
ModernaTX, Inc.Merck Sharp & Dohme LLCRecruitingSolid TumorsUnited States, Australia
-
Memorial Sloan Kettering Cancer CenterRecruitingMalignant Solid TumorsUnited States
-
National Cancer Institute (NCI)SuspendedNeoplasms | Solid TumorsUnited States
-
National Cancer Institute (NCI)Completed
-
Canadian Cancer Trials GroupBristol-Myers Squibb; Cancer Research Institute, New York City; Personal Genome...TerminatedAdvanced Solid TumorsUnited States, Canada
-
Hoffmann-La RocheCompletedSolid TumorsKorea, Republic of, Spain, Denmark, France, United Kingdom
-
TakedaActive, not recruiting
-
Merck Sharp & Dohme LLCCompleted
-
Basilea PharmaceuticaCompletedSolid Organ TumorsUnited Kingdom